- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Newly Approved Telehealth Guideline Causes a Stir
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit.
“This policy is a bold step toward a reality where all patients can access quality care irrespective of time, place and location,” said Dr. Roy Schoenberg, CEO of American Well, a Boston-based telemedicine technology and service provider that relies of video technology favored in the policy, in a news release. “Now that the federation has done its job as leaders, we look to states to do the same—embrace this model policy, and thereby ensure that only safe, secure and appropriate care can be delivered through today's telehealth technologies.”
The policy was approved with no changes, despite protests registered Friday during a committee hearing to gain public input, said Dr. Henry DePhillips, chief medical officer of Teladoc, which protested the policy's seeming restrictions on telephone-based physician-patient first encounters.
Read the full story here: http://bit.ly/1hKsByQ
Source: Modern Healthcare
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
